NCT05369611 2026-04-20
COVID-19 Experiences in the SELF Cohort
National Institutes of Health Clinical Center (CC)
Enrolling by invitation
Clinical Trials
18 trialsNCT07450833 2026-04-20
BOOST
Benfovir AG
Phase 1 Completed
NCT04474301 2026-04-16
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
M.D. Anderson Cancer Center
Recruiting
NCT04565665 2026-04-14
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT04387656 2026-04-13
NCI COVID-19 in Cancer Patients, NCCAPS Study
National Cancer Institute (NCI)
Active not recruiting
NCT04547634 2026-04-08
Telerehabilitation in Oncology Patients
University of Malaga
Phase NA Completed
NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
NCT05672355 2026-03-05
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 2 Recruiting
NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT03830320 2026-02-27
Positron Emission Tomography (PET) Imaging of Thrombosis
Massachusetts General Hospital
Phase 1 Recruiting
NCT04447222 2026-02-19
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
M.D. Anderson Cancer Center
Active not recruiting
NCT05022446 2026-02-13
The Impact of COVID-19 on Pulmonary Procedures
M.D. Anderson Cancer Center
Recruiting
NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
NCT04407143 2026-02-09
SOLID
Fundación GECP
Completed
NCT04357574 2026-02-06
CORONA-SHIELD
Duke University
Enrolling by invitation
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04491292 2026-01-28
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
M.D. Anderson Cancer Center
Recruiting
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed